The new D&D-seq molecular recording strategy utilizes base-editing enzymes and nanobodies to map DNA-protein interactions at single-cell resolution. This method captures transient regulatory contacts that often escape traditional assays, providing a clearer view of how gene activity is controlled in diverse cell types. By integrating into standard multiomics workflows, D&D-seq enables researchers to monitor how mutations and therapeutic interventions reshape the regulatory landscapes of patient-derived cells.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





